Compare BMRA & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMRA | FTHM |
|---|---|---|
| Founded | 1971 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 11.4M |
| IPO Year | 1995 | 2020 |
| Metric | BMRA | FTHM |
|---|---|---|
| Price | $1.78 | $0.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.9K | ★ 1.5M |
| Earning Date | 10-15-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | 32.71 |
| EPS | N/A | ★ N/A |
| Revenue | $4,453,000.00 | ★ $420,477,000.00 |
| Revenue This Year | N/A | $9.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.45 |
| 52 Week Low | $1.45 | $0.18 |
| 52 Week High | $3.21 | $1.84 |
| Indicator | BMRA | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 19.72 |
| Support Level | $1.50 | N/A |
| Resistance Level | $2.23 | $0.92 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 18.26 | 4.21 |
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.